Dr. Vandenbroucke’s career has been dedicated to Clinical Development, Medical Affairs, and Marketing in the U.S., Europe, Asia, and Latin America. Before his current position, he was responsible for Medical Strategy for Pfizer Inc. and for Medical Affairs of Pfizer’s Essential Health portfolio in North America.
He previously also led the Clinical Development of all Pfizer compounds in Asia, Central/Eastern Europe, Latin America, and Africa-Middle East and of Pfizer’s Established Products globally.
He was also responsible for developing compounds specifically for diseases of the developing world, such as malaria and river blindness.
Dr. Vandenbroucke serves on the Board of AFAR and BIO Ventures for Global Health. He is a member of the Advisory Boards of the Steve Biko Centre for Bioethics, University of the Witwatersrand-Johannesburg, the Canadian Institutes of Health Research, and the Keck Graduate Institute, Claremont, CA. He also is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Medicine of the United Kingdom.
A frequent speaker on health, aging, diversity, and policy issues, he is also a Visiting Senior Lecturer at King’s College and the Module Coordinator for Medical Affairs in the Medicines Development Certificate Program at IFAPP Academy and King’s College London.